These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10997985)

  • 1. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery.
    Batorova A; Martinowitz U
    Br J Haematol; 2000 Sep; 110(3):715-20. PubMed ID: 10997985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients.
    Négrier C; Shapiro A; Berntorp E; Pabinger I; Tarantino M; Retzios A; Schroth P; Ewenstein B
    Thromb Haemost; 2008 Aug; 100(2):217-23. PubMed ID: 18690340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of factor concentrates in children with haemophilia A in comparison with bolus injections.
    Bidlingmaier C; Deml MM; Kurnik K
    Haemophilia; 2006 May; 12(3):212-7. PubMed ID: 16643203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia.
    Park YS; Shin WJ; Kim KI
    BMC Musculoskelet Disord; 2017 Aug; 18(1):356. PubMed ID: 28830476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusion in haemophilia: current practice in Europe.
    Batorova A; Holme P; Gringeri A; Richards M; Hermans C; Altisent C; Lopez-Fernández M; Fijnvandraat K;
    Haemophilia; 2012 Sep; 18(5):753-9. PubMed ID: 22530687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of recombinant factor VIII formulated with sucrose in surgery: non-interventional, observational study in patients with severe haemophilia A.
    Meijer K; Rauchensteiner S; Santagostino E; Platokouki H; Schutgens RE; Brunn M; Tueckmantel C; Valeri F; Schinco PC
    Haemophilia; 2015 Jan; 21(1):e19-25. PubMed ID: 25458982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose continuous infusion of factor VIII in patients with haemophilia A.
    Prelog T; Dolničar MB; Kitanovski L
    Blood Transfus; 2016 Sep; 14(5):474-80. PubMed ID: 26674820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative treatment of hemophilia A patients: blood group O patients are at risk of bleeding complications.
    Hazendonk HC; Lock J; Mathôt RA; Meijer K; Peters M; Laros-van Gorkom BA; van der Meer FJ; Driessens MH; Leebeek FW; Fijnvandraat K; Cnossen MH
    J Thromb Haemost; 2016 Mar; 14(3):468-78. PubMed ID: 26714028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
    Dingli D; Gastineau DA; Gilchrist GS; Nichols WL; Wilke JL
    Haemophilia; 2002 Sep; 8(5):629-34. PubMed ID: 12199670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.
    Martinowitz U; Luboshitz J; Bashari D; Ravid B; Gorina E; Regan L; Stass H; Lubetsky A
    Haemophilia; 2009 May; 15(3):676-85. PubMed ID: 19298381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a randomized phase III/IV trial comparing intermittent bolus versus continuous infusion of antihaemophilic factor (recombinant) in adults with severe or moderately severe haemophilia A undergoing major orthopaedic surgery.
    Pabinger I; Mamonov V; Windyga J; Engl W; Doralt J; Tangada S; Spotts G; Ewenstein B
    Haemophilia; 2021 May; 27(3):e331-e339. PubMed ID: 33772963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous infusions of B domain-truncated recombinant factor VIII, turoctocog alfa, for orthopedic surgery in severe hemophilia A: first case report.
    Takeyama M; Nogami K; Kobayashi R; Ogiwara K; Taniguchi A; Nakanishi Y; Inagaki Y; Tanaka Y; Shima M
    Int J Hematol; 2018 Aug; 108(2):199-202. PubMed ID: 29383626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous infusion during total joint arthroplasty in Japanese haemophilia A patients: comparison study among two recombinants and one plasma-derived factor VIII.
    Takedani H
    Haemophilia; 2010 Sep; 16(5):740-6. PubMed ID: 20398072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery.
    Rochat C; McFadyen ML; Schwyzer R; Gillham A; Cruickshank A
    Haemophilia; 1999 May; 5(3):181-6. PubMed ID: 10444285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous infusion of factor VIII for surgery and major bleeding.
    Hay CR; Doughty HI; Savidge GF
    Blood Coagul Fibrinolysis; 1996 Mar; 7 Suppl 1():S15-9. PubMed ID: 8735792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience.
    Campbell PJ; Rickard KA
    Aust N Z J Med; 1998 Aug; 28(4):440-5. PubMed ID: 9777111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of continuous infusion with Beriate® P in patients with severe haemophilia A undergoing surgery - a subgroup analysis.
    Auerswald G; Bade A; Johne J; Haubold K; Overberg D; Masurat S; Moorthi C
    Thromb Res; 2014 Nov; 134 Suppl 1():S43-7. PubMed ID: 24360932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo stability of diluted recombinant factor VIII for continuous infusion use in haemophilia A.
    Revel-Vilk S; Blanchette VS; Schmugge M; Clark DS; Lillicrap D; Rand ML
    Haemophilia; 2010 Jan; 16(1):72-9. PubMed ID: 19765092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A.
    Hampton K; Chowdary P; Dunkley S; Ehrenforth S; Jacobsen L; Neff A; Santagostino E; Sathar J; Takedani H; Takemoto CM; Négrier C
    Haemophilia; 2017 Sep; 23(5):689-696. PubMed ID: 28470862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.